<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-0LJPKEFP/e24a2a8e-2c91-4b5b-b0ae-51a4982f23a9/HTML"><dcterms:extent>29 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-0LJPKEFP/85994262-db16-4d0a-abdf-592e9b3c4a61/PDF"><dcterms:extent>80 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-0LJPKEFP/ac1d7ea1-8e16-4252-b75c-8cd180e428de/TEXT"><dcterms:extent>27 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-0LJPKEFP"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2013</dcterms:issued><dc:creator>Writzl, Karin</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:82</dc:format><dc:format xml:lang="sl">str. 106-112</dc:format><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:773292</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-0LJPKEFP</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">chromosomal abnormality</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="en">embryo</dc:subject><dc:subject xml:lang="sl">kromosomske mutacije</dc:subject><dc:subject xml:lang="sl">monogenske bolezni</dc:subject><dc:subject xml:lang="en">PGD</dc:subject><dc:subject xml:lang="en">PGS</dc:subject><dc:subject xml:lang="sl">predimplantacijska genetska diagnostika</dc:subject><dc:subject xml:lang="sl">predimplantacijsko genetsko presejanje</dc:subject><dc:subject xml:lang="en">preimplantation genetic diagnosis</dc:subject><dc:subject xml:lang="en">preimplantation genetic screening</dc:subject><dc:subject xml:lang="en">single gene disorder</dc:subject><dc:subject xml:lang="sl">zarodek</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Predimplantacijska genetska diagnostika| Preimplantation genetic diagnosis|</dc:title><dc:description xml:lang="sl">Background: Preimplantation genetic diagnosis (PGD) is used to analyze embryos before their transfer into uterus. It is suitable for a group of patients who are at a substantial risk of conceiving a pregnancy affected by aknown genetic defect. PGD requires medically assisted reproduction, embryo biopsy of one or two cells and genetic analysis using either fluorescent in situ hybridization (FISH) or polymerase chain reaction. New technologies for PGD are now emerging. Array-based technologies allow simultaneous testing of aneuploidy and specific genetic diseases in each embryo. The main indications for PGD have been single gene disorders and in-herited chromosomal abnormalities. Preimplantation genetic screening (PGS) was introduced for aneuploidy screening, with the aim of replacing euploid embryos and increasingpregnancy rates in certain groups of patients undergoing in vitro fertilization procedures owing to infertility. Lately, several randomized control trials have failed to show that PGS on blastomeres using FISH method improved the delivery rate compared to the control group. The main reason is probably the natural occurrence of chromosomal mosaicism in the cleavage-stageembryo. Conclusions: Over the last two decades, PGD has been shown to be a reliable and safe genetic test for couples who are at risk of a specific inher - ited disorder. For PGS, the results from several ongoing randomized controlled trials performed at different cell biopsy stage, using array-CGH and SNP array will provide the data needed to evaluate the clinical efficacy</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-0LJPKEFP"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-0LJPKEFP" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-0LJPKEFP/85994262-db16-4d0a-abdf-592e9b3c4a61/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-0LJPKEFP/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-0LJPKEFP" /></ore:Aggregation></rdf:RDF>